The DCP Organ Systems Research Groups develop, support and oversee clinical cancer prevention trials and promote participation by all populations. The trials are designed to evaluate the safety and efficacy of promising new preventive agents, the utility of novel biomarkers and the value of innovative technologies to identify premalignant lesions. The Early Phase Cancer Prevention Clinical Trials Program facilitated through contracts and the grant funded Cancer Prevention Clinical Trials Network (CP-CTNet) were created to facilitate the efficient implementation of these studies by teams of multidisciplinary investigators.
- To stimulate information sharing and collaborations between DCP staff and Consortia/CP-CTNet members including investigators, program staff and coordinators; and
- To develop strategies to enhance the cancer prevention intervention research program both scientifically and operationally.
Consortia and CP-CTNet PIs, Program Staff, and Coordinators; DCP Regulatory, Repository, and Study Monitoring Staff; DCP Staff and Presenters.
- I-SCORE 2020 Agenda (
DOC, 140 KB)
Point of Contact
Questions and late registration queries about the I-SCORE Workshop may be directed to Perquita Perry via emailing her at: email@example.com.